Buy Rating Affirmed: TScan Therapeutics’ Innovative TCR-T Therapy and Strategic Milestones Promising for 2024
TScan Therapeutics First Quarter 2024 Earnings: Misses Expectations
Promising Clinical Results and Robust Financial Position Warrant a Buy Rating for TScan Therapeutics
TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates
TScan Therapeutics, Inc. (TCRX) Reports Q1 Loss, Lags Revenue Estimates
TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
TScan Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
Innovative T-Cell Therapy Approach: TScan’s Promising Outlook and Buy Rating by Gil Blum
Buy Rating Affirmed for TScan Therapeutics Amid Innovative Tumor Treatment and Promising Clinical Trials
TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors
TScan Therapeutics Announces First Patient Dosed in Phase 1 Clinical Trial Evaluating TCR-T Therapy for the Treatment of Solid Tumors
AnaptysBio, Inc. (ANAB) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
TScan Therapeutics, Inc. (TCRX) May Report Negative Earnings: Know the Trend Ahead of Q1 Release
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
TScan Therapeutics Announces Upcoming Presentations at the 2024 American Society of Clinical Oncology Annual Meeting
TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
TScan Therapeutics Announces Exercise of Underwriters' Option to Purchase Additional Shares
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.